Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 12, 2023

BUY
$5.76 - $12.48 $89,856 - $194,688
15,600 Added 62.15%
40,700 $282,000
Q4 2022

Feb 10, 2023

SELL
$8.86 - $25.04 $1.62 Million - $4.56 Million
-182,300 Reduced 87.9%
25,100 $258,000
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $1.49 Million - $6.24 Million
82,000 Added 65.39%
207,400 $3.78 Million
Q2 2022

Aug 12, 2022

SELL
$36.28 - $75.29 $1.25 Million - $2.59 Million
-34,400 Reduced 21.53%
125,400 $6.45 Million
Q1 2022

May 13, 2022

SELL
$69.73 - $142.9 $17.1 Million - $35.1 Million
-245,800 Reduced 60.6%
159,800 $11.8 Million
Q4 2021

Feb 11, 2022

BUY
$134.56 - $217.97 $29.1 Million - $47.1 Million
216,100 Added 114.04%
405,600 $58 Million
Q3 2021

Nov 12, 2021

SELL
$177.8 - $270.58 $25 Million - $38.1 Million
-140,700 Reduced 42.61%
189,500 $39.3 Million
Q2 2021

Aug 13, 2021

BUY
$121.0 - $257.67 $40 Million - $85.1 Million
330,200 New
330,200 $70.1 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.